New app will allow diabetics to manage condition on their iPhone

|

UPDATED:

00:42 GMT, 12 March 2012

Diabetics will be able to manage their condition with an Apple iPhone thanks to a device unveiled today.

The 48 glucose monitor allows patients to check their blood sugar levels at any time using the phone.

The iBGStar device, which attaches to an Apple iPhone or iPod touch, comes with a free Diabetes Manager App that makes it possible to store, track and analyse medical data.

Convenient: The iBGStar device can be attached to an iPhone or iPod touch

Convenient: The iBGStar device can be attached to an iPhone or iPod touch

Accurate monitoring of blood glucose is essential to the management of diabetes, which affects 2.9million people in the UK.

It is especially important for those with Type-1 diabetes, an auto-immune disease that can lead to dangerous rises in blood sugar levels.

High blood sugar can lead to serious complications including damage to the heart, kidneys, nerves and eyes.

Traditional blood glucose monitors are palm-sized devices that test tiny drops of blood obtained by pricking the skin.

Out with the old: Traditional blood glucose monitors test drops of blood taken by pricking the skin

Out with the old: Traditional blood glucose monitors test drops of blood taken by pricking the skin

iBGStar, available in Boots, works in the same way but is just one inch long and plugs straight into an iPhone or iPod Touch. Software carries out the analysis and flashes the results on to the screen.

Innovative: The new device plugs straight into an iPhone

Innovative: The new device plugs straight into an iPhone

It also allows users to follow changing trends and variations, and factors in information such as carbohydrate intake, insulin injections and exercise.

Sarah Johnson, from the type-1 diabetes research charity JDRF, said: 'Good blood glucose control is vital to reducing the long-term effects of diabetes, but it can be difficult and demanding to achieve.

'As such, we welcome all developments in technology that can help people with type-1 and type-2 diabetes take control of their condition.'

Dr Andrew Hockey, medical director for diabetes at the pharmaceutical company Sanofi, which produces the iBGStar, said the device was a 'huge step forward'.

'It harnesses the power of the latest technology to empower people with diabetes to manage their condition on a day-to-day basis,” he added.